The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain

Anesthesia and Analgesia

Volumn 87, Issue 6, 1998, Pages 1360-1366

  Abdi, Salahadin ^a   Lee, Doo Hyun ^b   Chung, Jin Mo ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; GABAPENTIN; LIDOCAINE;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPATHY; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

EID: 0344936034     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199812000-00027     Document Type: Article

References (32)

1. Ramsay RE. Clinical efficacy and safety of gabapentin. Neurology 1994;44:23-30.
2. Goldlust A, Su TZ, Welty DF, et al. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 1995;22:1-11.
3. Rowbotham MC. Chronic pain: from theory to practical management. Neurology 1995;45:5-10.
4. Thoren P, Oberg B. Studies on the endoanesthetic effects of lidocaine and benzonatate on non-medullated nerve endings in the left ventricle. Acta Physiol Scand 1981;lll:51-8.
5. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985;23:361-74.
6. Garfield JM, Gugino L. Central effects of local anesthetic agents. In: Strichartz GR, ed. Local anesthetics. Berlin: Springer-Verlag, 1987:253-84.
7. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-63.
8. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
9. Leem JW, Willis WD, Chung JM. Cutaneous sensory receptors in the rat foot. J Neurophysiol 1993;69:1684-99.
10. Ardid D, Guilbaud G. Antinociceptive effects of acute and "chronic" injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain 1992;49:279-87.
11. Chaplan SR, Bach FW, Shafer SL, et al. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology 1995;83:775-85.
12. Devor M, Jänig W, Michaelis M. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J Neurophysiol 1994;71:38-47.
13. Woolf CJ, Wall PD. The relative effectiveness of C-primary afferents of different origins in evoking a prolonged facilitation on the flexion reflex in the rat. J Neurosci 1986;6:1433-42.
14. Yoon YW, Na HS, Chung JM. Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 1996;64:27-36.
15. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992;51:175-94.
16. Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29: 233-49.
17. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996;12:56-8.
18. Hwang JH, Yaksh TL. Effect of subarachnoid gabapentin in tactile evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 1997;22:249-56.
19. Richens A. Clinical pharmacokinetics of gabapentin. In: Chadwick D, ed. New trends in epilepsy management: the role of gabapentin. London: Royal Society of Medical Services, 1993: 41-6.
20. Vollmer KO, von Hodenberg A, Kölle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneim Forsh Drug Res 1986;36:830-9.
21. Chapman V, Suzuki R, Chamarette HLC, et al. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998;75:261-72.
22. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 1991;47:644-66.
23. Spiegel K, Kalb R, Pasternak GW. Analgesic activity of tricyclic antidepressants. Ann Neurol 1983;13:462-5.
24. Richelson E. Antidepressants: pharmacology and clinical use. In: Treatments of psychiatric disorders. Vol. 3. Washington, DC: American Psychiatric Association, 1989:1773-86.
25. Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38: 1427-32.
26. Eisenach JC, Gebhart GF. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 1995;83: 1046-54.
27. Fromm GH, Nakata M, Kondo T. Differential action of amitriptyline on neurons in the trigeminal nucleus. Neurology 1991;41: 1932-6.
28. Seltzer Z, Tal M, Sharav Y. Autotomy behavior in rats following peripheral deafferentation is suppressed by daily injections of amitriptyline, diazepam and saline. Pain 1989;37:245-50.
29. Deffois A, Page D, Carter C. Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci Lett 1996;220:117-20.
30. Edwards WT, Habib F, Bumey RG, et al. Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases. Reg Aneth 1985;10:l-6.
31. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982;54:501-5.
32. Abram SE, Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 1994;80:383-91.